Xing Gong

Title: Innovations of Inventor Xing Gong

Introduction

Xing Gong is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies and their applications in disease treatment.

Latest Patents

Xing Gong holds 2 patents that showcase his innovative work. His latest patents include "LGR4 specific monoclonal antibodies and methods of their use," which provides isolated or recombinant anti-LGR4 monoclonal antibodies. These antibodies can be utilized for the detection, diagnosis, and therapeutic treatment of human diseases, including cancer. Another notable patent is "Regulation of Wnt/beta-catenin signaling," which describes a composition and method for detecting the ability of a compound to modulate the activity of LGR4, LGR5, or LGR6 receptors in a cell. These receptors are crucial for activating the Wnt/beta-catenin signaling system, which plays essential roles in embryonic development and the maintenance of adult stem cells.

Career Highlights

Xing Gong is affiliated with the University of Texas System, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on medical science and therapeutic applications.

Collaborations

Xing Gong collaborates with talented individuals such as Qingyun Liu and Kendra Carmon, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Xing Gong's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving human health.